GO:0050501 hyaluronan synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050501 hyaluronan synthase activity is a molecular function that catalyzes the alternating transfer of UDP-glucuronate and UDP-N-acetylglucosamine to form the glycosaminoglycan hyaluronan.
• The reaction produces a linear polymer of repeating disaccharide units, beta-N-acetyl-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3), while releasing UDP.
• In mammals, three hyaluronan synthase genes, HAS1, HAS2, and HAS3, encode enzymes with distinct catalytic properties and tissue distributions.
• HAS2 is the most widely expressed and is regulated by dimerization and ubiquitination, which control its stability and activity.
• Hyaluronan synthesis supports diverse physiological processes, including glutamate transporter activity in the nervous system and chondrocyte homeostasis.
• Dysregulated hyaluronan synthase activity is implicated in cancer progression, inflammation, and extracellular matrix remodeling.
Description
Hyaluronan synthase activity (GO:0050501) is a molecular function that produces hyaluronan, a large glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. This enzymatic activity is essential for the synthesis of hyaluronan, a key component of the extracellular matrix that influences cell proliferation, migration, and differentiation. The reaction catalyzed by hyaluronan synthase uses UDP-D-glucuronate and UDP-N-acetyl-D-glucosamine as substrates, alternately adding them to the reducing end of the growing hyaluronan chain while releasing UDP. In mammals, this activity is encoded by three genes: HAS1, HAS2, and HAS3, each exhibiting distinct catalytic rates and regulatory mechanisms. Researchers study hyaluronan synthase activity to understand tissue development, wound healing, inflammation, and cancer progression, as hyaluronan levels are often elevated in pathological conditions. The enzyme's activity can be measured using nonradioactive methods, facilitating investigations into its role in health and disease.
hyaluronan synthase activity At A Glance
| GO ID | GO:0050501 |
|---|---|
| GO term | hyaluronan synthase activity |
| Ontology | molecular_function |
| Synonym | HAS activity, seHAS, spHAS, alternating UDP-alpha-N-acetyl-D-glucosamine:beta-D-glucuronosyl-(1,3)-[nascent hyaluronan] 4-N-acetyl-beta-D-glucosaminyltransferase and UDP-alpha-D-glucuronate:N-acetyl-beta-D-glucosaminyl-(1,4)-[nascent hyaluronan] 3-beta-D-glucuronosyltransferase activity |
| Major function | Catalyzes the alternating addition of glucuronic acid and N-acetylglucosamine to form hyaluronan |
| Substrates | UDP-D-glucuronate and UDP-N-acetyl-D-glucosamine |
| Products | Hyaluronan polymer and UDP |
| Reaction direction | Polymerization |
| Cellular location | Plasma membrane |
What Is GO:0050501?
Hyaluronan synthase activity (GO:0050501) is defined as the catalysis of the reaction: UDP-D-glucuronate + UDP-N-acetyl-D-glucosamine = [beta-N-acetyl-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)](n) + 2n UDP. This activity alternately transfers glucuronic acid and N-acetylglucosamine from their respective UDP-sugar precursors to the nascent hyaluronan polymer, elongating the chain with repeating disaccharide units.
Why Is hyaluronan synthase activity Important in Cell Biology?
Hyaluronan synthase activity is critical for the biosynthesis of hyaluronan, a glycosaminoglycan that is a major component of the extracellular matrix and plays key roles in cell signaling, tissue hydration, and structural integrity. Alterations in hyaluronan synthesis are associated with numerous diseases, including cancer, where hyaluronan accumulation promotes tumor progression and metastasis. In the nervous system, hyaluronan synthesis supports glutamate transporter activity, influencing neurotransmission. In cartilage, HAS2 overexpression diminishes procatabolic activity in chondrocytes, suggesting a protective role in osteoarthritis. Understanding the regulation of hyaluronan synthase activity, including dimerization and ubiquitination of HAS2, provides insights into potential therapeutic targets.
• Hyaluronan is a key extracellular matrix component that regulates cell adhesion, migration, and proliferation.
• Hyaluronan synthase activity is essential for embryonic development, as HAS2 knockout mice exhibit lethal cardiac defects.
• Elevated hyaluronan levels are observed in many cancers and correlate with poor prognosis.
• HAS2 activity is regulated by dimerization and ubiquitination, affecting enzyme stability.
• Hyaluronan synthesis supports glutamate transporter activity in astrocytes, impacting neuronal function.
• HAS2 overexpression in chondrocytes reduces catabolic responses, indicating a role in cartilage protection.
• HAS1 is a mysterious enzyme with unexpected functions, including potential immunomodulatory roles.
• Nonradioactive methods to measure hyaluronan synthase activity facilitate drug discovery and basic research.
• Hyaluronan synthases are membrane-bound enzymes that extrude hyaluronan directly into the extracellular space.
• Targeting hyaluronan synthesis is a promising strategy for anticancer and anti-inflammatory therapies.
What Happens During hyaluronan synthase activity?
Substrate binding and initial transfer
In simple terms: The enzyme grabs two sugar building blocks and starts linking them together.
Hyaluronan synthase binds UDP-D-glucuronate and UDP-N-acetyl-D-glucosamine, the activated forms of glucuronic acid and N-acetylglucosamine. The enzyme catalyzes the transfer of one sugar to the other, forming the first disaccharide unit of the hyaluronan chain. This initial step is essential for subsequent elongation.
Alternating polymerization
In simple terms: The enzyme keeps adding alternating sugars to make a long chain.
After the initial disaccharide is formed, hyaluronan synthase alternately adds glucuronic acid and N-acetylglucosamine from their UDP-sugar precursors to the reducing end of the growing polymer. This process results in a linear chain of repeating disaccharide units, with the release of UDP for each sugar added.
Chain elongation and translocation
In simple terms: The long sugar chain is pushed out of the cell as it grows.
Hyaluronan synthase is a membrane-bound enzyme that synthesizes hyaluronan at the inner face of the plasma membrane and simultaneously translocates the growing polymer to the extracellular space. This unique mechanism allows hyaluronan to be directly deposited into the extracellular matrix without the need for vesicular transport.
Termination and release
In simple terms: The enzyme stops when the chain is long enough and releases it.
The polymerization reaction continues until the hyaluronan chain reaches a certain length, after which it is released from the enzyme. The length of the hyaluronan polymer can vary widely, influencing its biological functions.
Key Genes Involved in GO:0050501 hyaluronan synthase activity
The following genes encode proteins with hyaluronan synthase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HAS1 | Encodes hyaluronan synthase 1, a less active isoform | Associated with immune regulation and cancer |
| HAS2 | Encodes hyaluronan synthase 2, the predominant isoform | Essential for development, regulated by dimerization and ubiquitination |
| HAS3 | Encodes hyaluronan synthase 3, produces shorter hyaluronan chains | Involved in cell proliferation and migration |
| HAS2 | Regulated by TGF-beta and RAS signaling | Drives metastasis through enhancer remodeling |
| HAS2 | Supports glutamate transporter activity | Modulates neurotransmission |
| HAS2 | Overexpression diminishes chondrocyte catabolism | Potential therapeutic target for osteoarthritis |
| HAS1 | Mysterious enzyme with unexpected functions | Emerging role in inflammation |
| HAS3 | Produces hyaluronan in various tissues | Implicated in cancer progression |
| HAS2 | Dimerization regulates activity | Target for modulating hyaluronan synthesis |
| HAS2 | Ubiquitination controls stability | Affects enzyme turnover |
| HAS1 | Low catalytic activity | May have signaling functions independent of hyaluronan synthesis |
| HAS2 | Key role in embryonic heart development | Knockout is embryonic lethal |
| HAS3 | High catalytic activity in vitro | Used in biotechnological hyaluronan production |
| HAS2 | Involved in cancer metastasis | Target for anti-cancer therapy |
| HAS1 | Expressed in immune cells | Potential role in autoimmune diseases |
| HAS2 | Regulated by cytokines | Mediates inflammatory responses |
| HAS3 | Expressed in many tissues | Contributes to extracellular matrix homeostasis |
| HAS2 | Interacts with CD44 | Influences cell migration |
How Is hyaluronan synthase activity Regulated?
Hyaluronan synthase activity is regulated at multiple levels. HAS2, the major isoform, is controlled by dimerization and ubiquitination, which affect its stability and catalytic activity. Post-translational modifications, including phosphorylation and O-GlcNAcylation, can modulate enzyme function. Transcriptional regulation by growth factors and cytokines, such as TGF-beta and RAS, influences HAS2 expression and contributes to cancer metastasis. Additionally, the availability of UDP-sugar substrates and the cellular metabolic state can impact hyaluronan synthesis.
hyaluronan synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HAS2 | Cancer metastasis | HAS2 knockout cancer cell lines |
| HAS2 | Osteoarthritis | HAS2 overexpression in chondrocytes |
| HAS2 | Neurological disorders | HAS2 knockout neurons |
| HAS1 | Inflammation | HAS1 knockout immune cells |
| HAS3 | Cancer progression | HAS3 knockdown tumor models |
Cancer progression and metastasis
Hyaluronan synthase activity is often upregulated in cancer, leading to increased hyaluronan deposition in the tumor microenvironment. This promotes cell migration, invasion, and angiogenesis, and is associated with poor prognosis. TGF-beta and RAS signaling jointly unmask primed enhancers to drive HAS2 expression, facilitating metastasis.
Osteoarthritis and cartilage degradation
In chondrocytes, HAS2 overexpression diminishes procatabolic activity, suggesting that hyaluronan synthesis has protective effects in cartilage. Reduced hyaluronan levels in osteoarthritis may contribute to joint damage, making HAS2 a potential therapeutic target.
Neurological function and disease
Hyaluronan synthesis supports glutamate transporter activity in the nervous system, which is crucial for preventing excitotoxicity. Dysregulation of hyaluronan metabolism has been implicated in neurodegenerative conditions, although the exact mechanisms require further study.
From hyaluronan synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of HAS2 loss on tumor growth? | HAS2 knockout cell line |
| How does HAS2 dimerization affect enzyme activity? | Point mutation of dimerization interface |
| What is the role of HAS2 in heart development? | HAS2 knock-in reporter mouse |
| How does HAS2 overexpression affect chondrocyte catabolism? | HAS2 overexpression in chondrocytes |
| What is the impact of HAS1 on immune cell function? | HAS1 knockout mouse |
| How does HAS3 contribute to hyaluronan synthesis? | HAS3 overexpression cell line |
How to Study the hyaluronan synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Nonradioactive enzyme assay | Hyaluronan synthase activity | Drug screening and basic research |
| qRT-PCR | mRNA levels of HAS genes | Expression profiling |
| Western blot | HAS protein levels | Regulation studies |
| Immunofluorescence | Subcellular localization | Membrane localization |
| ELISA | Hyaluronan concentration | Extracellular matrix analysis |
| Cell migration assay | Cell motility | Cancer research |
| RNA-seq | Transcriptome changes | Pathway analysis |
| Proteomics | Protein interactions | Identifying regulators |
Measuring hyaluronan synthase activity
Nonradioactive methods have been developed to measure hyaluronan synthase activity, utilizing fluorescently labeled UDP-sugar substrates and separation techniques. These assays allow quantification of enzyme activity in cell lysates or purified membrane fractions.
Gene expression analysis
Quantitative RT-PCR and RNA-seq are used to measure HAS1, HAS2, and HAS3 mRNA levels in tissues and cells. This helps correlate enzyme expression with hyaluronan production and disease states.
Protein detection and localization
Western blotting and immunofluorescence can detect HAS protein levels and subcellular localization. These methods are useful for studying regulation by dimerization and ubiquitination.
Functional assays
Hyaluronan production can be assessed using ELISA-like assays or by measuring hyaluronan in conditioned media. Cell migration and proliferation assays can evaluate the biological consequences of altered hyaluronan synthesis.
How CRISPR Can Be Used to Study GO:0050501 hyaluronan synthase activity
Knockout
CRISPR knockout of HAS2 in cell lines or mice can abolish hyaluronan synthesis, leading to defects in extracellular matrix formation and embryonic development. Knockout models are valuable for studying the role of hyaluronan in cancer and tissue homeostasis.
Point Mutation
Introducing point mutations in the catalytic domain of HAS2 can dissect the enzymatic mechanism and identify residues critical for substrate binding and catalysis. Such mutants help distinguish between catalytic activity and non-enzymatic functions.
Knock-in
Knock-in of fluorescent tags or epitope tags into the endogenous HAS2 locus allows real-time visualization and purification of the enzyme. This approach facilitates studies on protein trafficking and interactions.
Overexpression
Overexpression of HAS2 or HAS3 in cell lines increases hyaluronan production and can promote cell migration and tumorigenesis. Overexpression models are used to study the consequences of elevated hyaluronan synthesis in diseases such as osteoarthritis.
How EDITGENE Supports hyaluronan synthase activity Research
Researchers studying hyaluronan synthase activity-related genes often need to determine whether a candidate gene is causally involved in hyaluronan synthesis, extracellular matrix remodeling, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of HAS genes and their regulatory networks.
Contact EDITGENE today to design your custom CRISPR model for hyaluronan synthase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| HAS1 Knockout HEK293 Cell Line | EDJ-KQ4841 | Human | 3036 | Details Get a Quote |
| HAS2 Knockout HEK293 Cell Line | EDJ-KQ4842 | Human | 3037 | Details Get a Quote |
| HAS3 Knockout HEK293 Cell Line | EDJ-KQ4843 | Human | 3038 | Details Get a Quote |
| HAS3 Knockout HCT 116 Cell Line | EDJ-KQ26410 | Human | 3038 | Details Get a Quote |
| HAS2 Knockout A-549 Cell Line | EDJ-KQ27624 | Human | 3037 | Details Get a Quote |
| HAS2 Knockout HeLa Cell Line | EDJ-KQ27625 | Human | 3037 | Details Get a Quote |
| HAS3 Knockout A-549 Cell Line | EDJ-KQ27626 | Human | 3038 | Details Get a Quote |
| HAS1 Knockout HeLa Cell Line | EDJ-KQ53490 | Human | 3036 | Details Get a Quote |
| HAS3 Knockout HeLa Cell Line | EDJ-KQ53491 | Human | 3038 | Details Get a Quote |
| HAS1 Knockout A-549 Cell Line | EDJ-KQ61962 | Human | 3036 | Details Get a Quote |
| HAS1 Knockout HCT 116 Cell Line | EDJ-KQ70442 | Human | 3036 | Details Get a Quote |
| HAS2 Knockout HCT 116 Cell Line | EDJ-KQ70443 | Human | 3037 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About hyaluronan synthase activity
What is hyaluronan synthase activity?
Hyaluronan synthase activity (GO:0050501) is the enzymatic function that catalyzes the synthesis of hyaluronan by alternately adding glucuronic acid and N-acetylglucosamine from UDP-sugar precursors.
What genes are involved in hyaluronan synthase activity?
The main genes are HAS1, HAS2, and HAS3, which encode distinct hyaluronan synthase enzymes in mammals.
What is the reaction catalyzed by hyaluronan synthase?
The enzyme catalyzes the reaction: UDP-D-glucuronate + UDP-N-acetyl-D-glucosamine = [beta-N-acetyl-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)](n) + 2n UDP.
How is hyaluronan synthase activity regulated?
HAS2 activity is regulated by dimerization and ubiquitination, as well as transcriptional control by growth factors and cytokines.
What diseases are associated with hyaluronan synthase activity?
Dysregulated hyaluronan synthesis is linked to cancer, osteoarthritis, and neurological disorders.
How can I measure hyaluronan synthase activity?
Nonradioactive methods using fluorescent substrates are available for measuring hyaluronan synthase activity in cell lysates.
What is the role of HAS2 in cancer?
HAS2 overexpression promotes hyaluronan accumulation, which enhances tumor cell migration and metastasis.
What is the difference between HAS1, HAS2, and HAS3?
They differ in catalytic activity, tissue distribution, and regulatory mechanisms, with HAS2 being the most widely expressed and essential for development.
Can hyaluronan synthase activity be targeted therapeutically?
Yes, inhibitors of hyaluronan synthesis are being explored for cancer and inflammatory diseases.
What model systems are used to study hyaluronan synthase activity?
Knockout mice, overexpression cell lines, and CRISPR-engineered models are commonly used.
Conclusion
Hyaluronan synthase activity (GO:0050501) is a fundamental enzymatic function responsible for the synthesis of hyaluronan, a critical extracellular matrix component. Its regulation and dysregulation impact development, cancer, and tissue homeostasis. Continued research using advanced CRISPR models and biochemical assays will further elucidate its roles and therapeutic potential.
References
- 1. Fallacara A et al.. 2018. Hyaluronic Acid in the Third Millennium.. Polymers (Basel) 10(7) PMID: 30960626
- 2. Lee JH et al.. 2024. TGF-β and RAS jointly unmask primed enhancers to drive metastasis.. Cell 187(22):6182-6199.e29 PMID: 39243762
- 3. Vigetti D et al.. 2022. A Nonradioactive Method to Measure Hyaluronan Synthase Activity.. Methods Mol Biol 2303:63-70 PMID: 34626370
- 4. Hayashi MK et al.. 2019. Hyaluronan synthesis supports glutamate transporter activity.. J Neurochem 150(3):249-263 PMID: 31188471
- 5. Ishizuka S et al.. 2019. Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan.. J Biol Chem 294(37):13562-13579 PMID: 31270213
- 6. Itano N et al.. 2002. Mammalian hyaluronan synthases.. IUBMB Life 54(4):195-9 PMID: 12512858
- 7. Siiskonen H et al.. 2015. Hyaluronan synthase 1: a mysterious enzyme with unexpected functions.. Front Immunol 6:43 PMID: 25699059
- 8. Karousou E et al.. 2010. The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination.. J Biol Chem 285(31):23647-54 PMID: 20507985
